chenodeoxycholic acid has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bhagani, S; Guaraldi, G; Ingiliz, P; Lemoine, M; Marzolini, C; Maurice, JB; Milic, J; Monteith, K; Morse, CG; Price, JC; Sebastiani, G; Tsochatzis, E | 1 |
Bridges, AS; Brouwer, KL; Corbett, AH; Kashuba, AD; McRae, M; Rezk, NL; Tien, HC | 1 |
2 other study(ies) available for chenodeoxycholic acid and HIV Coinfection
Article | Year |
---|---|
New Drugs for NASH and HIV Infection: Great Expectations for a Great Need.
Topics: Anti-Retroviral Agents; Chalcones; Chenodeoxycholic Acid; Cholic Acids; Clinical Trials, Phase III as Topic; Drug Interactions; HIV Infections; Humans; Imidazoles; Non-alcoholic Fatty Liver Disease; Propionates; Pyridazines; Sulfoxides; Uracil | 2020 |
Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.
Topics: Adult; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Chromatography, High Pressure Liquid; Early Diagnosis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lithocholic Acid; Liver; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tandem Mass Spectrometry; Taurocholic Acid; Time Factors | 2010 |